SOPHiA GENETICS SA (SOPH) has a MoatMap StockRank of 39/100 based on Quality (26/100), Value (36/100), and Momentum (64/100) factor scores. The current signal is HOLD. N/A
SOPHiA GENETICS is a Swiss-based technology company providing a data-driven medicine platform for healthcare institutions globally, with its AI-powered SOPHiA DDM™ analyzing genomic and radiomic data for clinical decision-making. The company's competitive advantage stems from its proprietary AI and machine learning algorithms, which aggregate and interpret large-scale genomic data from a vast network of partner institutions. This data-sharing ecosystem and advanced analytical capabilities position SOPHiA GENETICS as a leader in precision medicine informatics.
| Price | $4.88 |
| Market Cap | $350M |
| P/E (Forward) | -8.36 |
| Price/Book | 6.80 |
| Return on Equity | -123.3% |
| Return on Invested Capital | -64.8% |
| Debt/Equity | 136.63 |
| Gross Margin | 67.3% |
| Operating Margin | -79.7% |
| Revenue Growth | 22.0% |
| Free Cash Flow | $-25M |
SOPHiA GENETICS SA operates in the Health Information Services industry, part of the Healthcare sector (Switzerland).